Brivanib Alaninate
-
Catalog numberB1326-1
-
PricePlease ask
-
Size1 mg
-
-
Alternative_name[(2R)-1-[4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]oxypropan-2-yl] (2S)-2-aminopropanoate; BMS-582664
-
DescriptionBrivanib Alaninate is an ATP-competitive inhibitor of VEGFR2 with (IC₅₀ = 25 nM). Displays potent antineoplastic activity.
-
CAS Number649735-63-7
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₂H₂₄FN₅O₄
-
Molecular Weight441.46
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (>40 mg/ml)
-
HandlingProtect from air and light
-
Tag LineATP-competitive inhibitor of VEGFR2 with anticancer properties
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
PubChem CID11154925
-
SMILESCC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NN4C3=C(C(=C4)OCC(C)OC(=O)C(C)N)C
-
InChiInChI=1S/C22H24FN5O4/c1-11-7-15-16(27-11)5-6-17(19(15)23)32-21-20-13(3)18(8-28(20)26-10-25-21)30-9-12(2)31-22(29)14(4)24/h5-8,10,12,14,27H,9,24H2,1-4H3/t12-,14+/m1/s1
-
InChi KeyLTEJRLHKIYCEOX-OCCSQVGLSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameBrivanib Alaninate
-
Alternative nameBrivanib Alaninate
-